4Moving Biotech forms its Scientific Advisory Board of World-Renowned Knee Osteoarthritis Experts

4Moving Biotech, a subsidiary of 4P-Pharma, announces establishing an international Scientific Advisory Board in anticipation of its knee osteoarthritis drug candidate’s phase 2b clinical trial. This board, composed of eminent international experts, will play a key role in supporting the development of 4P004,…

Read More4Moving Biotech forms its Scientific Advisory Board of World-Renowned Knee Osteoarthritis Experts

GenScript ProBio Signs Viral Vector Manufacturing MOU With Curocell for Next-Generation CAR-T Therapy

On November 10, a global multimodality CDMO, GenScript ProBio and specialized CAR-T therapy firm Curocell signed a strategic partnership MOU for the production of viral vectors necessary for the development of next generation of CAR-T therapy, marking another significant step…

Read MoreGenScript ProBio Signs Viral Vector Manufacturing MOU With Curocell for Next-Generation CAR-T Therapy

CVS Health Foundation awards $3 million in grants to increase access to mental health services and resources for adolescents

CVS Health Foundation today announced it has awarded $3 million in grants over five years to advance mental health equity to Healthy Start Coalition of Hillsborough County in Florida, Meadows Mental Health Policy Institute in Texas and the Rosecrance Foundation…

Read MoreCVS Health Foundation awards $3 million in grants to increase access to mental health services and resources for adolescents

Chemed Corporation’s Board of Directors Authorizes an Additional $300 Million for Stock Repurchase

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed’s existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as…

Read MoreChemed Corporation’s Board of Directors Authorizes an Additional $300 Million for Stock Repurchase

Baxter Highlights New Data at Kidney Week Indicating Sharesource is Associated with a 77% Lower Risk of Home Dialysis Technique Failure

Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, announced today new data indicating Baxter’s Sharesource remote patient management (RPM) digital platform, when used with an automated peritoneal dialysis (PD) system, is associated with a 77% reduction…

Read MoreBaxter Highlights New Data at Kidney Week Indicating Sharesource is Associated with a 77% Lower Risk of Home Dialysis Technique Failure

ATEC Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Adjusted EBITDA Guidance

Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended September 30, 2023, and recent corporate highlights. Third Quarter 2023 Financial Results   Quarter EndedSeptember 30,…

Read MoreATEC Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Adjusted EBITDA Guidance